[Therapeutic considerations on colibacillosis].
D004927:Escherichia coli Infections / Q000188:drug therapy*; D006801:Humans; D009355:Neomycin / Q000627:therapeutic use*; D009536:Niacinamide / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use*; D013432:Sulfathiazoles / Q000627:therapeutic use*; D014812:Vitamin K / Q000627:therapeutic use*
D013432:Sulfathiazoles; D014812:Vitamin K; D009536:Niacinamide; D009355:Neomycin; D012256:Riboflavin
Considerações terapêuticas na colibacilose.